09.01.05
Valensa International, (formerly U. S. Nutra), Eustis, FL, has indicated that a New Dietary Ingredient (NDI) notification to sell its Zanthin brand natural astaxanthin dietary supplement, has been reviewed without objection by the FDA. The company may now offer the product for sale and use in the U.S. as a human dietary supplement ingredient. This news follows Zanthin’s recent approval, under Regulation (EC) No. 258/97, from the U.K. Food Standards Agency (FSA), which recognized Zanthin as a non-novel dietary supplement, allowing it to be marketed at a maximum dose of 4 mg daily in the 25 member countries of the European Union.